CoChat
Sign Up
Cited by 400

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels

Mertins, Philipp, Yang, Feng, Liu, Tao, Mani, D.R., Petyuk, Vladislav A., Gillette, Michael A., Clauser, Karl R., Qiao, Jana W., Gritsenko, Marina A., Moore, Ronald J., Levine, Douglas A., Townsend, Reid, Erdmann-Gilmore, Petra, Snider, Jacqueline E., Davies, Sherri R., Ruggles, Kelly V., Fenyo, David, Kitchens, R. Thomas, Li, Shunqiang, Olvera, Narciso, Dao, Fanny, Rodriguez, Henry, Chan, Daniel W., Liebler, Daniel, White, Forest, Rodland, Karin D., Mills, Gordon B., Smith, Richard D., Paulovich, Amanda G., Ellis, Matthew, Carr, Steven A.·2014·Molecular & Cellular Proteomics
DOI 10.1074/mcp.m113.036392
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/mcp.m113.036392

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Phosphorylation at corresponding sites in SNX1, SNX3, SNX12, and SNX17 has been reported in various cancer types.

    “phosphorylation at corresponding sites in SNX1, SNX3, SNX12, and SNX17 has been reported in various cancer types (47, 48, 49, 50, 51, 52)”

    From Phosphorylation of SNX17 impedes activation of Retriever-mediated sorting (2025) · cites this paper as [47]

    The Results passages discuss phosphorylation in tumor samples, including EGFR and stress-kinase pathways, but do not identify phosphorylation sites in SNX1, SNX3, SNX12, or SNX17. Searches for those protein names and for sorting-neXIN phosphorylation found no passage in our copy establishing the claimed sites across cancer types. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

  • Increased phosphorylation of SNX3 and SNX17 PIP-stop motifs has been observed during cold ischemia, coinciding with MAPK stress-response pathway activation.

    “increased phosphorylation of SNX3 and SNX17 PIP-stop motifs has been observed during cold ischemia, coinciding with MAPK stress-response pathway activation (47).”

    From Phosphorylation of SNX17 impedes activation of Retriever-mediated sorting (2025) · cites this paper as [47]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Cancer Genome Atlas Research Network, 2011, Integrated genomic analyses of ovarian carcinoma, Nature, 474, 609, 10.1038/nature10166 · DOI · Paper page
  2. Cancer Genome Atlas Research Network, 2013, Integrated genomic characterization of endometrial carcinoma, Nature, 497, 67, 10.1038/nature12113 · DOI · Paper page
  3. Salvesen, 2009, Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation, Proc. Natl. Acad. Sci. U.S.A, 106, 4834, 10.1073/pnas.0806514106 · DOI
  4. Ellis, 2012, Whole-genome analysis informs breast cancer response to aromatase inhibition, Nature, 486, 353, 10.1038/nature11143 · DOI
  5. Hennessy, 2010, A technical assessment of the utility of reverse phase protein arrays for the study of the functional proteome in non-microdissected human breast cancers, Clin. Proteomics, 6, 129, 10.1007/s12014-010-9055-y · DOI
  6. Wisniewski, 2013, Proteomic workflow for analysis of archival formalin-fixed and paraffin-embedded clinical samples to a depth of 10 000 proteins, Proteomics Clin. Appl, 7, 225, 10.1002/prca.201200046 · DOI
  7. Mertins, 2012, iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics, Mol. Cell. Proteomics, 11, 10.1074/mcp.M111.014423 · DOI
  8. Huttlin, 2010, A tissue-specific atlas of mouse protein phosphorylation and expression, Cell, 143, 1174, 10.1016/j.cell.2010.12.001 · DOI · Paper page
  9. Lundby, 2012, Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues, Nat. Commun, 3, 876, 10.1038/ncomms1871 · DOI · Paper page
  10. Mertins, 2013, Integrated proteomic analysis of post-translational modifications by serial enrichment, Nat. Methods, 10, 634, 10.1038/nmeth.2518 · DOI
  11. Neumeister, 2012, Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues, J. Natl. Cancer Inst, 104, 1815, 10.1093/jnci/djs438 · DOI
  12. Yildiz-Aktas, 2012, The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma, Mod. Pathol, 25, 1098, 10.1038/modpathol.2012.59 · DOI
  13. Espina, 2008, A portrait of tissue phosphoprotein stability in the clinical tissue procurement process, Mol. Cell. Proteomics, 7, 1998, 10.1074/mcp.M700596-MCP200 · DOI
  14. Ahmed, 2011, Preserving protein profiles in tissue samples: differing outcomes with and without heat stabilization, J. Neurosci. Methods, 196, 99, 10.1016/j.jneumeth.2011.01.004 · DOI
  15. Gündisch, 2012, Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phase, J. Proteome Res, 11, 5748, 10.1021/pr300560y · DOI
  16. Li, 2013, Intrinsic indicators for specimen degradation, Lab. Invest, 93, 242, 10.1038/labinvest.2012.164 · DOI
  17. Ross, 2004, Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents, Mol. Cell. Proteomics, 3, 1154, 10.1074/mcp.M400129-MCP200 · DOI · Paper page
  18. Li, 2013, Endocrine therapy resistant ESR1 variants revealed by genomic characterization of breast cancer derived xenografts, Cell Reports, 4, 1116, 10.1016/j.celrep.2013.08.022 · DOI
  19. Ding, 2010, Genome remodelling in a basal-like breast cancer metastasis and xenograft, Nature, 464, 999, 10.1038/nature08989 · DOI
  20. Wang, 2011, Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells, Proteomics, 11, 2019, 10.1002/pmic.201000722 · DOI
  21. Kumar, 2007, Mfuzz: a software package for soft clustering of microarray data, Bioinformation, 2, 5, 10.6026/97320630002005 · DOI
  22. Franceschini, 2013, STRING v9.1: protein-protein interaction networks, with increased coverage and integration, Nucleic Acids Res, 41, D808, 10.1093/nar/gks1094 · DOI · Paper page
  23. Hornbeck, 2012, PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse, Nucleic Acids Res, 40, D261, 10.1093/nar/gkr1122 · DOI
  24. Winograd-Katz, 2006, Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor, Oncogene, 25, 7381, 10.1038/sj.onc.1209737 · DOI
  25. Bagowski, 1999, Cell-type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor, EMBO J, 18, 5567, 10.1093/emboj/18.20.5567 · DOI
  26. Dougherty, 2002, Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress, Biochem. J, 362, 561, 10.1042/bj3620561 · DOI
  27. Harris, 2007, American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer, J. Clin. Oncol, 25, 5287, 10.1200/JCO.2007.14.2364 · DOI
  28. Hatzis, 2011, Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers, J. Natl. Cancer Inst, 103, 1871, 10.1093/jnci/djr438 · DOI
  29. Gillette, 2013, Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry, Nat. Methods, 10, 28, 10.1038/nmeth.2309 · DOI
  30. Gündisch, 2013, Delayed times to tissue fixation result in unpredictable global phosphoproteome changes, J. Proteome Res, 12, 4424, 10.1021/pr400451z · DOI
  31. Pinhel, 2010, Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer, Breast Cancer Res, 12, R76, 10.1186/bcr2719 · DOI
  32. Gauthier, 2007, Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors, Cancer Cell, 12, 479, 10.1016/j.ccr.2007.10.017 · DOI · Paper page
  33. Schiff, 2000, Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo, J. Natl. Cancer Inst, 92, 1926, 10.1093/jnci/92.23.1926 · DOI
  34. Huang da, 2009, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nat. Protoc, 4, 44, 10.1038/nprot.2008.211 · DOI · Paper page
  35. Manning, 2002, The protein kinase complement of the human genome, Science, 298, 1912, 10.1126/science.1075762 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Mertins, P., Yang, F., Liu, T., Mani, D. R., Petyuk, V. A., Gillette, M. A., Clauser, K. R., Qiao, J. W., Gritsenko, M. A., Moore, R. J., Levine, D. A., Townsend, R., Erdmann-Gilmore, P., Snider, J. E., Davies, S. R., Ruggles, K. V., Fenyo, D., Kitchens, R. T., Li, S., Olvera, N., Dao, F., Rodriguez, H., Chan, D. W., Liebler, D., White, F., Rodland, K. D., Mills, G. B., Smith, R. D., Paulovich, A. G., Ellis, M., & Carr, S. A.
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2014-07
Volume
13
Issue
7
Pages
1690-1704
ISSN
1535-9476
DOI
10.1074/mcp.m113.036392
Cited by
400
References
6
Language
en
Licence
Funders
National Institutes of Health (U24CA160034, U24CA160019, U24CA160035, U24CA159988, U24CA160036, P30CA091842, 3P50 CA68438, CA016672, PO1CA099031, U54CA112970, KG081694, P30 CA16672)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review